Commencement of Share Buyback Programme

Summary by AI BETAClose X

Rentokil Initial plc has announced the commencement of a share buyback programme with an aggregate value of up to USD 200 million, which will begin immediately and conclude no later than 24 February 2027. The company has engaged Goldman Sachs International to execute these purchases on various stock exchanges, with the aim of reducing issued share capital and fulfilling obligations under employee share schemes. Shares acquired will be cancelled or held in treasury. This programme operates under the company's general authority granted by shareholders on 7 May 2026, which permits the repurchase of up to 252,000,000 shares.

Disclaimer*

Rentokil Initial PLC
27 October 2026
 

 

27 October 2026               

 

Rentokil Initial plc (the “Company”)

 

Commencement of share buyback programme

 

 

 

The Company announces that, further to its announcement on 22 October 2026 of the Company's third quarter trading update for the period 1 July 2026 to 30 September 2026,  it will commence a share buyback programme to purchase ordinary shares in the Company ("Shares") with an aggregate value of up to USD 200 million (the "Programme").

 

In connection with the Programme, the Company has entered into an agreement with Goldman Sachs International (“GSI”) in relation to the purchase by GSI, acting as principal and in accordance with certain pre-set parameters, of Shares. Under this agreement, the Company has instructed GSI to purchase Shares with an aggregate value of up to USD 200 million. Purchases of the Company’s Shares pursuant to the Programme will commence immediately and will end no later than 24 February 2027. GSI will make trading decisions in relation to the Programme independently of, and uninfluenced by, the Company with regard to the timing of the purchases. Any purchase of Shares by GSI contemplated by this announcement will be carried out on the London Stock Exchange, Cboe Europe Limited through the BXE and CXE order books, Aquis Stock Exchange and/or Turquoise. Shares purchased by GSI will be on-sold by GSI to the Company, and any purchases of Shares by the Company from GSI under the Programme will be carried out on the London Stock Exchange.

 

The purpose of the Programme is to reduce the issued share capital of the Company and to meet obligations arising under the Company’s employee share schemes. Shares purchased under the Programme will be cancelled or held in treasury and may be used to satisfy future obligations arising under the Company’s employee share schemes.

 

Any purchases under the Programme shall take place in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase Shares granted by its shareholders at the Annual General Meeting on 7 May 2026 (the "2026 Authority") and any further authority to repurchase Shares as may be granted by its shareholders from time to time and Chapter 9 of the Financial Conduct Authority's UK Listing Rules. The maximum number of Shares that the Company is authorised to purchase under the 2026 Authority is 252,000,000. Purchases of Shares by GSI under the Programme shall also take place in accordance with the Market Abuse Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) No 2016/1052 (each as incorporated into UK domestic law by virtue of the European Union (Withdrawal) Act 2018).

 

The Company will make further regulatory announcements to shareholders in respect of purchases of Shares under the Programme by no later than the end of the 7th daily market session following the date of such purchase.

 

Enquiries:

 

For further information, please contact:

 

Investors / Analysts:

Heather Wood, Rentokil Initial plc, +44 7808 098793

Jamie Lewis, Rentokil Initial plc, +44 7341 071944

 

Media:

Malcolm Padley, Rentokil Initial plc, +44 7788 978199

 

 

About Rentokil Initial plc

 

Rentokil Initial plc is a global leader in Pest Control and Hygiene & Wellbeing services. It employs c.63,400 people in 90 countries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings